세계 코로나 바이러스 백신 시장 : 백신 유형별, 유통 채널별, 지역별

Global Coronavirus Vaccine Market is estimated to be valued at US$ 43.9 Bn in 2023, and is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 43.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.40%	2030 Value Projection:	US$ 72.3 Bn

Figure 1. Global Coronavirus Vaccine Market Share (%), By Vaccine Type, 2023

Coronavirus disease (COVID-19) is an infectious disease that is caused by the SARS-CoV-2 virus. It is contagious and spreads quickly, and causes mild to moderate respiratory illness. The manufacturing and development of vaccine are basically of three types the whole-microbe vaccine approach which has inactivated vaccine, live-attenuated vaccine, and viral vector vaccine; the sub-unit approach which consists of protein or sugar subunit of a virus and genetic material approach vaccine that has dna or RNA of the virus. According to the data published by World Health Organization(WHO), in January, 2023, 183 corona virus vaccine are in clinical development and 199 are in pre clinical development. Vaccination is the best method to control the rising cases of coronavirus cases across the globe. The increasing number of COVID-19 cases is expected to support growth of the market over the forecast period. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths due to coronavirus (COVID-19) were reported up till May 30, 2021 globally. Key players are actively involved in increasing their research and development activities and clinical trials, and this is expected to drive the global coronavirus vaccine market growth.

Market Dynamics

Key players in the vaccine industry are focusing on the development of new vaccines. Moreover, increasing investments by government to support manufacturing and distribution of COVID-19 vaccines is expected to propel the market growth. For instance, on September 13, 2023, Centers for Disease Control and Prevention (CDC) recommended any one six months and older to get the new dose of COVID vaccine. Introduction of such regulations by government is expected to drive growth of the global coronavirus vaccine market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global coronavirus vaccine market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global coronavirus vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer-BioNtech, AstraZeneca, Bharat Biotech, Johnson & Johnson Services, Inc, Moderna, Inc., Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., Sanofi S.A., Novavax, Inc., Symvivo, CanSinoBIO, CureVac AG, Zydus Cadila, Arcturus Therapeutics Holdings Inc., and Entos Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global coronavirus vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronavirus vaccine market

Global Coronavirus Vaccine Market Detailed Segmentation:

• By Vaccine Type:
  • Inactivated Virus
  • Protein Subunit
  • Non-replicating Viral Vector
  • Repurposed Vaccines
  • RNA Vaccine
  • DNA Vaccine
• By Distribution Channel:
  • Government Channel
  • Hospital and Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Pfizer-BioNtech
  • AstraZeneca
  • Bharat Biotech.
  • Johnson & Johnson Services, Inc
  • Moderna, Inc.
  • Sinovac Biotech Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Sanofi S.A.,
  • Novavax, Inc.
  • Symvivo
  • CanSinoBIO
  • CureVac AG
  • Zydus Cadila
  • Arcturus Therapeutics Holdings Inc.
  • Entos Pharmaceuticals

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Vaccine Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Coronavirus Vaccine Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Coronavirus Vaccine Market, By Vaccine Type, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Inactivated Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Protein Subunit
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Non-replicating Viral Vector
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Repurposed Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• RNA Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• DNA Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

6. Global Coronavirus Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Government Channel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Hospital and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Coronavirus Vaccine Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Company Profiles
  • Pfizer-BioNtech
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • AstraZeneca
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Bharat Biotech
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Johnson & Johnson Services, Inc
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Moderna, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Sinovac Biotech Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Serum Institute of India Pvt. Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Sanofi S.A.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Novavax, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Symvivo
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • CanSinoBIO
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • CureVac AG
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Zydus Cadila
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Arcturus Therapeutics Holdings Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Entos Pharmaceuticals
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact